CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ¼Û¿µ½Å
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : °©»ó¼±Áúȯ/´ç´¢º´/±âŸ ³»ºÐºñ ´ë»çÁúȯ
  • Á÷ À§: Á¶±³¼ö
  • ¸Þ ÀÏ: ºñ°ø°³
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
59 (±¹¿Ü)SCIE Type 2 diabetes is associated with low muscle mass in older adults
58 (±¹¿Ü)SCI The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels
57 (±¹¿Ü)SCI Effects of patient?tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low?density lipoprotein cholesterol in patients with type 2 diabetes
56 (±¹³»)KCIÈĺ¸ Drug Therapy for Obesity
55 (±¹³»)KCI Mangement of Type2 diabetes mellitus in older adults
54 (±¹³»)±âŸ ´ç´¢º´ÀÌ Ä¡¸Å¿¡ ¹ÌÄ¡´Â ¿µÇâ ¹× ¿¹¹æ¹ý
53 (±¹³»)SCOPUS Management of Type 2 Diabetes Mellitus in Older Adults
52 (±¹¿Ü)SCI Impaired Colony-Forming Capacity of Circulating EndothelialProgenitor Cells in Patients with Emphysema
51 (±¹³»)KCIÈĺ¸ Exercise and Type 2 Diabetes: ACSM and ADA Joint Position Statement
50 (±¹³»)±âŸ ½ÄÈÄ °íÇ÷´çÀÇ ÃøÁ¤ ¹× Ä¡·á¸ñÇ¥
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 13 14 15 16 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729